Zgwatinib | MedChemExpress (MCE)
Zgwatinib (SOMG-833) is a potent, selective, and ATP-competitive c-MET inhibitor, with an IC50 of 0.93 nM against c-MET, over 10,000-fold more potent compared with 19 tyrosine kinases (including c-MET family members and highly homologous kinases). Zgwatinib potently inhibits c-MET-driven cell proliferation. Zgwatinib as a potential candidate agent for c-MET-driven human cancers research[1].
Trivial name | Zgwatinib |
Catalog Number | HY-124267 |
Alternative Name(s) | SOMG-833 |
Research Area | Cancer |
CAS# | 1268264-10-3 |
Purity | ≥98.00% |
SMILES | O=[N+]([O-])C1=CC(CNC2=C3C=C(C=NC3=CC(C(F)(F)F)=C2)N4CCN(CC4)C)=CC=C1 |
PubChem Chemical Structure ID | 50997095 |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/zgwatinib.html |